Cite
Abemaciclib restricts HCMV replication by suppressing pUL97-mediated phosphorylation of SAMHD1.
MLA
Syrigos, Georgios Vavouras, et al. “Abemaciclib Restricts HCMV Replication by Suppressing PUL97-Mediated Phosphorylation of SAMHD1.” Antiviral Research, vol. 217, Sept. 2023, p. 105689. EBSCOhost, https://doi.org/10.1016/j.antiviral.2023.105689.
APA
Syrigos, G. V., Feige, M., Dirlam, A., Businger, R., Gruska, I., Wiebusch, L., Hamprecht, K., & Schindler, M. (2023). Abemaciclib restricts HCMV replication by suppressing pUL97-mediated phosphorylation of SAMHD1. Antiviral Research, 217, 105689. https://doi.org/10.1016/j.antiviral.2023.105689
Chicago
Syrigos, Georgios Vavouras, Maximilian Feige, Alicia Dirlam, Ramona Businger, Iris Gruska, Lüder Wiebusch, Klaus Hamprecht, and Michael Schindler. 2023. “Abemaciclib Restricts HCMV Replication by Suppressing PUL97-Mediated Phosphorylation of SAMHD1.” Antiviral Research 217 (September): 105689. doi:10.1016/j.antiviral.2023.105689.